Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Wednesday 22 April 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 403 -(TSXV: $KHRN.V) (OTCQX: $KHRNF) (OTC: $GRCU) (TSXV: $NRTH.V)



Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 403 -(TSXV: $KHRN.V) (OTCQX: $KHRNF) (OTC: $GRCU) (TSXV: $NRTH.V)



Delta, Kelowna, BC, April 22, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s podcast will be looking at a few public company announcements.

But first, in case you missed it this 4/20, Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from KCSA's April 20th Cannabis and Psychedelics conference are now available for on-demand viewing at VirtualInvestorConferences.com.

REGISTER OR LOGIN NOW AT:  https://tinyurl.com/420PostPR

April 20th Presenting Companies: 
Company Name
Ticker(s)
Field Trip Psychedelics Inc.
Private Company
Psybio Therapeutics, Inc.
Private Company
Eleusis Ltd.
Private Company
Back of the Yards Algae Sciences (BYAS)
Private Company
ATAI Life Sciences AG
Private Company
Fire & Flowers Holding Corp.
(OTCQX: FFLWF |TSX: FAF)
4Front Ventures Corp.
(OTCQX: FFNTF | CSE: FFNT)
MariMed Inc.
The Valens Company
MediPharm Labs Corp.
Tabula Rasa Ventures
Private Company

Phil Carlson, Managing Director at KCSA Strategic Communications, said, "I'd like to thank all the speakers that joined us for the KCSA Cannabis and Psychedelics Virtual Investor Conference. We heard presentations from industry experts on the applications of psychedelics in the treatment of mental health, as well as insights on the future of the cannabis industry and the strategies operators are implementing to build their operations during the next phase of the sector's evolution."


Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) a vertically integrated cannabis leader with core operations in Latin America and Europe, announced that it has entered into a sales and distribution agreement with Locatel, a pharmacy, healthcare products, and medical equipment retailer with a database of over 2 million patients in Colombia. The agreement immediately brings Khiron's medical cannabis products to Locatel's pharmacies and medical equipment stores in Bogota and Cartagena.

"Khiron is the only company to have all necessary permits and certificates to sell medical cannabis in Colombia, and now the focus is on service and solving patient needs for the last mile," comments Alvaro Torres, Khiron CEO and director. "The Locatel brand is highly respected among Colombians and the company's philosophy aligns with our own. We look forward to partnering with Locatel to improve access to medical cannabis for patients throughout the country."
Effective immediately Khiron's low-THC, CBD-rich magistral preparations will be available through Locatel stores across Colombia's largest urban centres, including in Bogota, with a population of 10 million, and Cartagena, with a population of 1 million.

"This has always been about providing people with medicine they vitally need, and it must be available with home delivery, and for pick up at trusted locations such as Locatel," Torres continued.

Green Cures & Botanical Distribution, Inc. (OTC: GRCU) a manufacturer, wholesaler and distributor of hemp and CBD-infused nutritional, sports, body care and alcoholic spirits products, announced production efforts are underway for Hollywood Green Botanical Vodka.

Hollywood Green was approved by the Alcohol Tobacco & Tax Bureau (“TTB”) late last year and is set to officially launch in May.  The company has forged a partnership to sell Hollywood Green initially online where it will be available for purchase and direct delivery to customers’ homes.

Hollywood Green will be available in 28 states to start, including AK, AZ, CA, CO, CT, DC, GA, IA, ID, IN, KS, LA, ME, MN, MO, MT, NC, NE, NJ, NM, NV, NY, OH, RI, SC, WI, and WY. 

Green Cures will continue to solidify more online distributor and retail networks with the goal to expand to every state where it’s legal to sell and deliver spirits online.

Green Cures has updated its marketing site for Hollywood Green at www.hollywoodgreenvodka.com which will be used for brand updates, reviews and where to buy Hollywood Green.  As volume grows online the company will solidify relationships with national and regional distributors for broader distribution.

Additionally, the company announced it is in discussions with a new partner to launch a “Navy Strength” high-proof Gin.  The parties are finalizing designs and expect to submit to the TTB by next week.  Navy Strength is a relatively new term where the spirit is bottled at exactly 57% alcohol by volume, or 114 proof.  This product will be positioned as a premium/high end spirit.  Updates will be forthcoming and the partnership is expected solidified and announced next week.

48North Cannabis Corp. (TSXV:NRTH) announced that it has shipped the first order of its accessible dried flower brand, Fleur du Jour, to the Société québécoise du cannabis ("SQDC") for retail sale.

Today, 48North is bringing affordable quality cannabis to the Quebec recreational market. Building on the Company's belief that high-quality cannabis experiences should be available to all, 48North's low-cost production advantage allows the Company to produce this product at competitive pricing.

"As we continue to listen to consumer feedback, we know that price point is a critical driver of purchasing decisions and are confident this will match demand for more affordable products. With that in mind, the launch of Fleur du Jour is a critical step in our renewed commitment to improving operations, investing in product development, and supporting high-quality experiences for Canadian consumers," said Charles Vennat, CEO of 48North.

Fleur du Jour will retail at the SQDC both online and in retail stores, the Company expects that this will be one of the most accessible products available to cannabis customers in Quebec, without jeopardizing quality.

Looking ahead, 48North has a number of additional product launches that are expected to launch this quarter, these include:
     Apothecanna, Extra Strength Body Cream (Alberta)
     Trail Mix, Pax Pod (Ontario)
     Trail Mix, All-in-one accessible vaporizer pen (Ontario)
     48North, indoor premium dried flower (Ontario and Alberta)
     Avitas, single strain vaporizer cartridge (Alberta)

Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) a vertically-integrated provider of premium-quality medical cannabis operating under the Fluent™ brand, continued its Florida expansion, celebrating the April 21st opening of a new dispensary in East Orlando – its 20th Florida dispensary and its third in the Orlando metro area. 

The Company's newest dispensary is located at 10607 E. Colonial Drive, Orlando. The 3,200 square foot site, together with the Company's existing Downtown Orlando dispensary at 1901 North Orange Avenue, and its Casselberry dispensary at 487 State Road 436, will serve Orlando's 2.5 million residents and millions of annual tourists. The new site is conveniently located less than 30 miles from Disney World, Universal Studios, International Drive and the Orlando airport and less than 4 miles from the campuses of the University of Central Florida and Valencia College, which have combined enrollments of nearly 90,000 students.

Cansortium's Executive Chairman Neal Hochberg noted, "We continue to expand our Florida dispensary network, enhancing access to premium-quality Fluent cannabis products for medical marijuana patients across the state. As one of the first five licensed operators in Florida, we are proud to be able to continue serving Florida's large and growing population of medical marijuana patients through the challenges posed by the COVID-19 pandemic. All of our dispensaries remain open following Florida Governor Ron DeSantis' April 3, 2020 Stay-at-Home order, which specifically designated medical marijuana as one of several essential services."

Mr. Hochberg concluded, "The health and safety of our employees, each of the Florida patients and the communities in which we operate is our primary concern. As part of our efforts to help slow the spread of COVID-19 in accordance with guidelines from State and local health authorities, we are prioritizing Express Pick-up orders, including curbside and drive-through pick-up. In addition, each of our 20 locations across the state has implemented additional cleaning and sanitation procedures, as well as social distancing protocols."

The Fluent brand continually strives to set the standard for premium quality, consistently-formulated cannabis products. Each of the Company's Florida dispensaries carries a complete assortment of Fluent premium dried flower, and full spectrum concentrates and cartridges as well as creams, drops, capsules and suppositories. All Fluent products in the Company's Florida dispensaries use high-quality cannabis that is cultivated, processed and packaged in the company's state-of-the-art Florida facilities in strict compliance with Florida regulations. For consumers, the sleek, modern dispensaries provide a warm, welcoming, professional environment, with private consultation rooms and knowledgeable staff who carefully guide patients in selecting the right products and carefully safeguard patient privacy.

The new East Orlando dispensary is the Company's second opening of 2020 and one of several more at various stages of construction and approval that the Company expects to add to its network this year.

For a complete list of Fluent dispensary locations, current promotions and rewards programs and hours of operation, or to explore the entire Fluent product line and place an online order for home delivery anywhere in Florida, visit https://getfluent.com/.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


  





Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Tuesday 21 April 2020

Investorideas.com - National Cannabis Industry Association to Host Earth Day Webinar on Sustainable Cannabis Cultivation

Investorideas.com - National Cannabis Industry Association to Host Earth Day Webinar on Sustainable Cannabis Cultivation

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) (FSE: TH8) Executes Diversification Division Announcing First Signed Crop Management Contract

Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) (FSE: TH8) Executes Diversification Division Announcing First Signed Crop Management Contract

www.investorideas.com - news that inspires big ideas

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 402 - (OTC: $SKDI) (OTC: $CURR), (OTC: $PSYC) (OTCQX: $MRMD)



Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 402 - (OTC: $SKDI) (OTC: $CURR), (OTC: $PSYC) (OTCQX: $MRMD)



Delta, Kelowna, BC, April 21, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s podcast will be looking at a few public and private company announcements.

Sun Kissed Industries Inc. (OTC:SKDI), an emerging leader in the CBD Food and Beverage marketplace, announced that its recent acquisition, Products Group Inc, DBA/ Hakuna Supply, has completed expansion and installation of its new Clean Room facility, which includes a newly installed industrial mixer, a Nespresso Capsule filling machine, and a Bagged Coffee filling machine.
                   
The new Clean Room facility has sharply increased the Company's revenues and productive output:            
     Nespresso Capsule production increased from 2,000/day to 10,000/day
     Bagged Coffee filling machine driving 500% increase in per day bagged coffee production
     New capability to produce single serve instant coffee pouches
     Cost of goods sold expected to drop approximately 30% on a per unit basis
                                       
"The results of our hard-working team have resulted in significantly increased output across all our product lines and decreased order-to-shipment time frames," commented Hakuna CEO, Ilan Freeman. "In addition, we have seen demand increase over the past couple of months ahead of our expanded marketing efforts."
                   
The newly expanded and enhanced Clean Room went into full use at the beginning of April. Hakuna online sales have increased 30% since the COVID-19 'lock-downs'. The expanded facilities and new equipment, along with increased marketing investments, have Hakuna projecting increased revenues across all online product lines on a month-over-month and year-over-year basis.
                   
Hakuna, a wholly owned subsidiary, is an award-winning CBD-products company, currently nominated for "Best Hemp-Derived CBD Product" by the California Cannabis Awards after winning the DOPE Magazine Best New Product award for Southern California in the non-cannabis/non-tech category in 2017. Hakuna was also just awarded "Runner Up" at the Los Angeles Coffee & Donut Festival People's Choice Coffee Awards for 2019. Hakuna generates significant revenues with a substantial distribution footprint, including over 110 established retail distribution partners across over 20 states in the domestic US market.

CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the issuance of two U.S. Patents: No. 10,639,339 and 10,624,940. These patents represent an expansion of CURE’s existing “product by process” patents for obtaining multiple unique cannabis concentrates using super critical fluid extraction (SCFE). These include cannabinoid concentrates enriched in cannabidiol (CBD), tetrahydrocannabinol (THC) and cannabigerol (CBG), a non-psychoactive cannabinoid which has shown promising therapeutic activity in animal studies in areas such as inflammatory bowel disease, cancer and infectious diseases.

“Adding CBG to our SCFE patent portfolio aligns with the latest research and early clinical evidence supporting its therapeutic benefit,” said Rob Davidson, CEO of CURE Pharmaceutical. “We continue to expand this portfolio to the latest commercial applications for SCFE, providing our patent licensees and their customers expanded IP rights.”
CURE is granting equipment manufacturers, cannabis processing companies and cannabinoid drug developers licenses to its portfolio of issued and pending process and composition patents for isolating cannabinoids using an advanced SCFE technology utilizing carbon dioxide as the solvent. While the patents cover the incorporation of cannabis extracts into multiple dosage forms, CURE has retained all rights to applying these methods in oral thin films.

The two patents cover the extraction and purification of cannabis plant material, as well as subsequent processing of cannabis extracts for drug formulation. This extraction and fractioning of bioactive cannabinoid molecules allows for the integration of these molecules into dosage forms.

Global Trac Solutions, Inc. (OTC: PSYC) announced that they have engaged with a variety of key industry experts in an effort to plan and prepare for the Company’s intended initial launch set for May 2020. Such efforts have included identifying and establishing strategic partnerships with various individuals and companies whom PSYC will look to collaborate with over the next several weeks and months. The Company will be working on collaborations in the areas of media, website and brand strategy as it positions itself for what it anticipates to be a very effective launch into the emerging business sector of psychedelic medicine.

“In recent weeks we have witnessed our world and our daily lives change significantly as a result of the ongoing COVID-19 pandemic. We have also seen a steady increase in studies and overall focus surrounding a variety of alternative medicines and treatments, including those associated with psychedelics based on the possible benefits for treating anxiety, depression, PTSD, and more. Most recently Rolling Stone Magazine published an interesting article surrounding Swiss chemist Albert Hoffmann’s psychedelic discovery, and in it they state, ‘More recently, Silicon Valley billionaires have been examining the profitability of the industry, neuro-pharmaceutical corporations are developing commercial psychedelic compounds, and the Wall Street Journal is covering psychedelic startups.’ We were fortunate to watch the cannabis industry grow into a sustainable marketplace for both medicinal and recreational use. Part of that journey surrounded research and development including working alongside industry experts to gain the knowledge and understanding needed to service that industry. We will be embarking on the same path for psychedelic medicine by engaging with industry experts, which will likely expand to a new advisory board and a more defined approach, which will result in a unique plan to engage this market,” said Vanessa Luna, CEO of PSYC.

PSYC is at the forefront of psychedelic medicine, we will work with several ancillary businesses to provide a network of resources for our current subscribers, while expanding that network to those pioneers advocating for change and legislation within this arena.

MariMed Inc. (OTCQX: MRMD) announced today that Betty's Eddies™, its proprietary, in-house award-winning national cannabis brand, will now be available for retail purchase in Nevada. The expansion is part of MariMed’s plan to increase the licensing and distribution of its proprietary Brands and Products into high-growth legal state markets.

Betty’s Eddies has been one of the top performing cannabis brands in multiple states across the country, earning the LeafLink award for Best Selling Medical Product in 2019.  Betty's Eddies are gluten-free, vegan fruit chews made from organically grown fruits and vegetables. Containing full spectrum cannabis oil, Betty’s Eddies are produced in a wide variety of dosages and flavors, also offering limited edition varieties by market. Betty’s Bedtime variety has proven to be a top seller in all markets, helping our customers achieve much needed rest and sleep.

In Nevada, MariMed has partnered with Solace Holdings at their state-of-the-art licensed production and manufacturing facility in Las Vegas.  A variety of Betty’s Eddies are now being sold in Nevada, and can be found at Nuwu Dispensary in Elko, Nevada, with several more retail locations to be added this month.

Ryan Crandall, Chief Product Officer and SVP of Sales at MariMed, Inc., commented, "With a successful launch in the Massachusetts market and continued growth in Maryland and Rhode Island, Betty's Eddies has achieved substantial sales growth through the last quarter of 2019 into the first quarter of 2020. The Betty’s brand is one of the most popular cannabis brands in the United States today, with innovative new varieties appealing to a wide range of consumer preferences. As we continue to grow into new markets, we have the opportunity to serve a broader consumer profile and therefore to evolve our product offerings in line with the market demand.”

According to BDS Analytics, Nevada surpassed retail sales expectations in its first year of adult-use sales, and sales are expected to surpass $1.2 billion by 2022. With over 45 million visitors a year from all over the world, Nevada is a key market to building an internationally recognized cannabis brand.

Bob Fireman, CEO of MariMed, Inc., commented, “As the cannabis marketplace continues to grow and cannabis consumers explore new and health-focused consumption options, we believe demand for our brands in Nevada and across our other markets will grow in lock step. MariMed is dedicated to producing the safest, highest quality products and we are excited to introduce them to Nevada adult-use consumers.”

CannaTrac® Technology, Inc., the leading cashless payment solution for the cannabis and hemp industries, announced today that the Company is accepting applications for retailers looking to adopt the CannaCard® cashless payment system in Illinois, California, Florida and Ohio.

“We are thrilled to be accepting applications from retailers and dispensaries looking to adopt the CannaCard cashless payment platform in California, Illinois, Florida and Ohio,” said CannaTrac Vice Chairman and CEO Thomas Gavin IV. “As we continue bringing more retailers on to the CannaCard system, we look forward to doing our part to increase health and safety standards during these trying times for both consumers and retailers.”

By offering CannaCard®, retailers are improving consumer experience through convenience, increasing safety and providing a healthier environment for employees, consumers and the community through contactless payments. Retailers interested in adopting the CannaCard® can apply at https://cannatrac.com/apply/. CannaCard® applications serve a dual purpose by allowing cannabis businesses to apply for both acceptance into the cashless payment software system and a hard-to-come-by bank account with one form.

In the coming months, CannaTrac expects to launch the CannaCard® in several additional high demand markets across the U.S.


Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


  





Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory


Drug Enforcement Agency (DEA) Reschedules Cannabis from Schedule I to Schedule III

Drug Enforcement Agency (DEA) Reschedules Cannabis from Schedule I to Schedule III : Drug Enforcement Agency (DEA) Reschedules Cannabis from...